The general conclusions of these experiments are that ximelagatran will not be inferior to standard therapy for that acute therapy of DVT and it is remarkable to placebo for extended secondary prevention of recurrent DVT and/or PE. Fourteen per cent of melagatran is excreted from the urine after administration of https://bilobetin76543.digitollblog.com/26849852/top-latest-five-pf-9363-urban-news